Sign In

Luke Hanley

Research Associate II - AAV Therapeutics Research Group at CRISPR Therapeutics

Luke Makana Hanley is a research professional currently working at CRISPR Therapeutics as a Senior Research Associate in Research Innovation.3 He has been with CRISPR Therapeutics since August 2018.3 Hanley specializes in biomedical engineering and has experience in AAV (Adeno-Associated Virus) therapeutics research.

Previously, Hanley worked at Addgene as a Research Team Lab Tech, where he focused on methods to improve AAV production.1 He has authored blog posts on the importance of high titer for AAV transductions, demonstrating his expertise in this area.1

Hanley received his education from Tufts University.2 He is based in the Medford area and has over 500 connections on LinkedIn.2 His email address is [email protected] and his phone number is 978-888-5261.4

In his current role, Hanley is likely involved in developing innovative gene therapies using CRISPR technology, particularly those involving AAV as a delivery vector for genetic material.

Highlights

Mar 1 · blog.addgene.org
The Importance of High Titer for AAV Transductions - Addgene Blog
The Importance of High Titer for AAV Transductions - Addgene Blog

Related Questions

What specific projects is Luke Makana Hanley working on at CRISPR Therapeutics?
How did Luke Makana Hanley transition from Addgene to CRISPR Therapeutics?
What are Luke Makana Hanley's main responsibilities in the AAV Therapeutics Research Group?
What are some recent advancements in AAV production that Luke Makana Hanley might be involved in?
How does Luke Makana Hanley's work contribute to the development of gene therapies at CRISPR Therapeutics?
Luke Hanley
Luke Hanley, photo 1
Luke Hanley, photo 2
Add to my network

Location

Cambridge, Massachusetts, United States